Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 10/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.45 |
| ▸ | DPP4 | P27487 | 2/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17328158 | 0.92 | ENPP2 (0.50) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17317759 | 0.92 | ENPP2 (0.50) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17317601 | 0.92 | ENPP2 (0.50) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17328136 | 0.91 | KCNK3 (0.45) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17328192 | 0.91 | KCNK3 (0.45) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17317490 | 0.91 | KCNK3 (0.45) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17328080 | 0.90 | ENPP2 (0.47) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17328165 | 0.90 | ENPP2 (0.47) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL19097241 | 0.90 | ENPP2 (0.47) | KCNK3ENPP2DPP4DPP8DPP7 | |
| SCHEMBL17328183 | 0.90 | KCNK3 (0.46) | KCNK3ENPP2DPP4DPP8DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015188051-A1 | ATX MODULATING AGENTS | BIOGEN MA INC. (US) | 2015-12-10 | — | — | WO | disclosed |